Comparative effects of glucagon-like peptide 1 receptor agonists and metformin on glaucoma risk in patients with type 2 diabetes
Glucagon Receptor Activation The addition of glucagon receptor activation distinguishes Retatrutide from all currently approved medications
It is estimated that approximately 936 million adults worldwide suffer from moderate-to-severe OSAS, the vast majority of whom remain undiagnosed (3)
Your provider tracks not just the scale but waist circumference, strength markers, and metabolic indicators to ensure you are losing fat, not the muscle that keeps you strong
You may be able to get Wegovy or Mounjaro if: You are 18 or older You have a high BMI (at least 35 kg/m2) + have a health problem like: Type 2 diabetes High blood pressure High cholesterol Sleep problems (like sleep apnoea) Heart disease To be used alongside a reduced-calorie diet and increased physical activity Please note, NHS eligibility for GLP-1 injections is different from the regulatory guidelines mentioned above
Its important to follow your providers instructions closely and attend your scheduled follow-up visits
